Exercise & Sports Science Australia (ESSA) position statement on exercise prescription for patients with peripheral arterial disease and intermittent claudication

Askew, Christopher D., Parmenter, Belinda, Leicht, Anthony S., Walker, Philip J. and Golledge, Jonathan (2013) Exercise & Sports Science Australia (ESSA) position statement on exercise prescription for patients with peripheral arterial disease and intermittent claudication. Journal of Science and Medicine in Sport, 17 6: 623-629. doi:10.1016/j.jsams.2013.10.251

Attached Files (Some files may be inaccessible until you login with your UQ eSpace credentials)
Name Description MIMEType Size Downloads

Author Askew, Christopher D.
Parmenter, Belinda
Leicht, Anthony S.
Walker, Philip J.
Golledge, Jonathan
Title Exercise & Sports Science Australia (ESSA) position statement on exercise prescription for patients with peripheral arterial disease and intermittent claudication
Journal name Journal of Science and Medicine in Sport   Check publisher's open access policy
ISSN 1440-2440
1878-1861
Publication date 2013-11-11
Year available 2013
Sub-type Critical review of research, literature review, critical commentary
DOI 10.1016/j.jsams.2013.10.251
Open Access Status
Volume 17
Issue 6
Start page 623
End page 629
Total pages 7
Place of publication Chatswood, NSW, Australia
Publisher Elsevier Australia
Language eng
Formatted abstract
Objectives Peripheral arterial disease (PAD) is characterised by atherosclerotic stenosis or occlusion of the arteries of the lower limbs, resulting in an impairment of blood flow to the legs. Patients with PAD have a significant reduction in their physical capacity and are limited during activities such as walking by intermittent claudication.

Design Position stand.

Methods Synthesis of published work within the field of exercise training and peripheral arterial disease.

Results
Supervised exercise training is considered the most effective treatment for increasing exercise tolerance in patients with PAD, and is also associated with improvements in daily physical activity and quality of life, and a reduction is cardiovascular disease risk. Exercise should be prescribed and progressed for patients individually, taking into consideration their disease severity, exercise tolerance and relevant comorbidities.

Conclusions While walking programs are beneficial and frequently prescribed, other forms of aerobic exercise such as cycling or arm-cranking may also be incorporated as tolerated by patients. Forty minutes of accumulated aerobic activity, three times per week, is recommended for most patients. Patients should be encouraged to commence exercise at a moderate intensity, and should stop and rest if claudication pain becomes severe. Resistance training should also be included on at least two days per week with the goal of improving muscular strength and endurance. Comorbidities such as musculoskeletal complaints, hypertension, diabetes and peripheral neuropathy are common in patients with PAD and may exacerbate their functional limitations. Given the high cardiovascular risk associated with PAD, it is important that patients are appropriately monitored during exercise.
Keyword Exercise therapy
Resistance training
Exercise test
Cardiovascular diseases
Arterial occlusive diseases
Exercise physiology
Q-Index Code C1
Q-Index Status Confirmed Code
Institutional Status UQ
Additional Notes Available online 11 November 2013

Document type: Journal Article
Sub-type: Critical review of research, literature review, critical commentary
Collections: UQ Centre for Clinical Research Publications
Official 2014 Collection
School of Medicine Publications
 
Versions
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 7 times in Thomson Reuters Web of Science Article | Citations
Scopus Citation Count Cited 9 times in Scopus Article | Citations
Google Scholar Search Google Scholar
Created: Wed, 11 Dec 2013, 21:44:54 EST by Roheen Gill on behalf of Surgery - Royal Brisbane and Women's Hospital